SymbioMatch ApS
CVR 44559374 · Private limited company (ApS) · Active · Low risk
SymbioMatch ApS is a Private limited company (ApS), founded on , based in Aarhus C. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -2.9m and a net result of DKK -1.8m. CEO: Marcela Alejandra Mendoza Suarez, Stig Uggerhøj Andersen.
Bankruptcy risk for SymbioMatch ApS
0.6 × the average (1.41%) · higher risk than 69% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44559374
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (2 years)
- Address
- c/o Institut for Molekylærbiologi og Genetik, Universitetsbyen 81
8000 Aarhus C - Municipality
- Aarhus
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- Kovsted & Skovgård, Statsautoriseret revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -136.4% |
| Current ratio | 980% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 1 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -618k | DKK -215k |
| Net profit | DKK -1.8m | DKK -1.1m |
| Equity | DKK -2.9m | DKK -1.1m |
| Total assets | DKK 2.1m | DKK 3.1m |
| Cash | DKK 1.5m | – |
| Short-term debt | DKK 215k | – |
| Avg. employees | 3 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Kovsted & Skovgård, Statsautoriseret revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 117 | ||
| 11 Jan 2024 – 31 Dec 2024 | 179 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Marcela Alejandra Mendoza Suarez | Current | |
| CEO | Stig Uggerhøj Andersen | Current | |
| CEO | Marcin Jakub Nadzieja | ||
| Owner (67%) | Marcela Alejandra Mendoza Suarez | Current | |
| Owner (25%) | Stig Uggerhøj Andersen | Current | |
| Owner (50%) | Marcela Alejandra Mendoza Suarez | ||
| Owner (20%) | Stig Uggerhøj Andersen | ||
| Owner (20%) | Marcin Jakub Nadzieja | ||
| Founder | Marcela Alejandra Mendoza Suarez | Current | |
| Founder | Stig Uggerhøj Andersen | Current | |
| Founder | Marcin Jakub Nadzieja | Current |
Address history (1 moves)
| c/o Institut for Molekylærbiologi og Genetik, Universitetsbyen 81, 8000 Aarhus C | |
| c/o BII, Ole Maaløes Vej 3, 2200 København N |
Other companies at the same address
- Commit Biologics ApS Active
Similar companies in Aarhus
- Resiliency Centre ApS Aarhus N
- AptaShape ApS Aarhus C
- Aptamist ApS Lystrup
- Mmimetika ApS Aarhus N
- MKR Finans APS Aarhus C
- Cystotech ApS Aarhus C
- IMCOR ApS Egå
- Commit Biologics ApS Aarhus C
- Økologisk Komplementarselskab ApS Aarhus N
- MyGold ApS Aarhus C
- UNIKUM Therapeutics ApS Risskov
- Solsten Diagnostics International ApS Aarhus N
Questions and answers about SymbioMatch ApS
Has SymbioMatch ApS gone bankrupt?
No, SymbioMatch ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of SymbioMatch ApS?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the CEO of SymbioMatch ApS?
Marcela Alejandra Mendoza Suarez, Stig Uggerhøj Andersen are the CEOs of SymbioMatch ApS.
Who is the auditor of SymbioMatch ApS?
SymbioMatch ApS most recently used Kovsted & Skovgård, Statsautoriseret revisionspartnerselskab.
When was SymbioMatch ApS founded?
SymbioMatch ApS was founded on 11 January 2024.
What is the equity of SymbioMatch ApS?
Equity was DKK -2.9m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.